CD8A and neoplasm: Although CD8+ T-cell infiltration increased 7 days after treatment in the best-performing dose, this observation coincided with the tumor returning to exponential tumor growth, which suggests that the remaining tumor was able to recover and continue growing despite early immune cell infiltration.